GoodRx Holdings, Inc. (NASDAQ: GDRX) reported Q2 EPS of $0.09, $0.01 worse than the analyst estimate of $0.10. Revenue for the quarter came in at $203.1 million versus the consensus estimate of $205.87 million.

For earnings history and earnings-related data on GoodRx Holdings, Inc. (GDRX) click here.